MaxCyte shares are growing against the background of increasing recommendations and pulse in the field of genes editing News ad
MaxCyte today $ 4.66 -0.10 (-2.10%) As of 01.24.2025 16:00 East 52-week range $ 3.16 ▼ $ 5.29 Target price 9.50 US dollars Maksit INC. Nasdak: MXCT – Global developer of new generation cell therapy. They provide the most important technologies for cellular and gene therapy. Their main tools of Expert ATX, STX, GTX and … Read more
